Ascent Pharmaceuticals, Inc. v. U.S. Drug Enforcement Administration
| Ascent Pharmaceuticals, Inc. |
| U.S. Drug Enforcement Administration |
| 2:2023cv07211 |
| September 27, 2023 |
| US District Court for the Eastern District of New York |
| Gary R Brown |
| Arlene R Lindsay |
| Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision |
| 05 U.S.C. ยง 551 Administrative Procedure Act |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 3, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Civil Case Terminated. (KM) |
| Filing 5 NOTICE of Voluntary Dismissal by Ascent Pharmaceuticals, Inc. (Walden, James) |
| Filing 4 Summons Issued as to U.S. Drug Enforcement Administration. (AC) |
| Filing 3 Clerk's Notice Re: Consent. A United States Magistrate Judge has been assigned to this case and is available to conduct all proceedings. In accordance with Rule 73 of the Federal Rules of Civil Procedure, Local Rule 73.1, the parties are notified that if all parties consent, the assigned Magistrate Judge is available to conduct all proceedings in this action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to this Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. Any party may withhold its consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent.The form may also be accessed at the following link: #https://img.nyed.uscourts.gov/files/forms/MJConsentForm.pdf (AC) |
| Filing 2 This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (AC) |
| Case Assigned to Judge Gary R. Brown and Magistrate Judge Arlene R. Lindsay. Please download and review the Individual Practices of the assigned Judges, located on our #website. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (AC) |
| Filing 1 COMPLAINT against U.S. Drug Enforcement Administration filing fee $ 402, receipt number ANYEDC-17127714 Was the Disclosure Statement on Civil Cover Sheet completed -NO,, filed by Ascent Pharmaceuticals, Inc.. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons, #3 Declaration of Jim Walden, #4 Exhibit 1, #5 Exhibit 2, #6 Exhibit 3, #7 Exhibit 4, #8 Exhibit 5, #9 Exhibit 6, #10 Exhibit 7) (Walden, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Ascent Pharmaceuticals, Inc. v. U.S. Drug Enforcement Administration | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Ascent Pharmaceuticals, Inc. | |
| Represented By: | James A Walden |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: U.S. Drug Enforcement Administration | |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
